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Abstract
 
Although stable repression of CD4 and CD8 genes is a central feature of T cell lineage commit-
ment, we lack detailed information about the timing and mechanism of this repression. Stable gene
repression has been linked to the position of genes within the nucleus. Therefore, information
about the nuclear position of CD4 and CD8 genes during T cell development could provide
insights into both the mechanism of regulation of CD4 and CD8 genes, and the process of lineage
commitment. Here, we report that lineage-specific repression of CD4 and CD8 genes is associ-
ated with the repositioning of alleles close to heterochromatin. We also provide evidence that
the relocalization of CD4 and CD8 genes to heterochromatin can occur as an early response to
positive selection signals. We discuss our results in terms of our current knowledge of CD4 and
CD8 gene regulation and CD4 versus CD8 lineage commitment.
Key words: lineage commitment • heterochromatin • positive selection • gene repression • 
nuclear position
 
Introduction
 
The two major lineages of mature T cells are distinguished
by expression of the cell surface proteins CD4 and CD8.
CD4 and CD8 are coreceptors that bind to MHC class II
and I, respectively, and cooperate with the TCR to recog-
nize peptide–MHC complexes during antigen recognition
in the periphery, and during T cell selection in the thymus.
In the thymus, early T cell progenitors initially lack CD4
and CD8 expression (CD4
 
  
 
CD8
 
 
 
, double negative [DN]
thymocytes), and then turn on expression of both corecep-
tors (CD4
 
  
 
CD8
 
 
 
, double positive [DP] thymocytes). DP
thymocytes then undergo a stringent selection process to
ensure that their newly formed TCRs have a weak reactiv-
ity to self-peptide/MHC (positive selection), and are not
strongly self-reactive (negative selection). After positive
selection, DP thymocytes down-regulate either CD4 or
CD8 to give rise to mature thymocytes (CD4
 
  
 
CD8
 
  
 
or
CD4
 
  
 
CD8
 
  
 
single positive [SP] thymocytes). The decision
to down-regulate CD4 or CD8 is linked to the specificity
of TCR for MHC class I or II. Thymocytes that undergo
positive selection via recognition of MHC class I down-
regulate CD4 and give rise to mature CD8 T lineage cells.
In contrast, thymocytes that undergo positive selection via
MHC class II down-regulate CD8 and give rise to CD4
lineage T cells. Thus, the down-regulation of CD4 and
CD8 in the thymus is tightly linked to the processes of pos-
itive selection and lineage commitment.
Because of their central role in T cell function, and their
prominence as differentiation markers for T cells, consider-
able effort has gone into understanding the regulation of
CD4 and CD8 genes (for review see references 1–3). CD4
repression in DN and CD8 SP thymocytes is largely con-
trolled by an intronic silencer (4) and Runx transcription
factors (5–7). Other transcription factors including SAF and
HES have also been implicated in CD4 regulation. For
CD8, a number of cis- and trans-acting factors have been
identified as positive regulators of gene expression, includ-
ing Ikaros (8). Other transcription factors have been impli-
cated in CD4 and CD8 T cell development including
GATA3, which is required for CD4 T cell development
(9, 10), and Tox, which can promote CD8 T cell develop-
ment when ectopically expressed (11). How these tran-
scription factors work together during the development of
CD4 and CD8 T cells, and how they are regulated by posi-
tive selection signals, is not yet clear. In addition to cis-acting
DNA sequences, and the transcription factors that bind
them, information about mechanism of gene regulation can
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also come from analysis of the position of alleles within the
nucleus (12–15). This type of approach has not yet been
applied to the study of CD4 and CD8 gene regulation dur-
ing thymic development.
Progress in understanding the mechanism of CD4/CD8
lineage commitment would be advanced by assays to assess
the early stages of lineage commitment. In theory, this
could be done by examining the initial down-regulation of
the CD4 and CD8 genes. However, attempts to define in-
termediate stages of positive selection by identifying thy-
mocyte populations expressing intermediate levels of sur-
face CD4 and CD8, have led to surprising results. For
example, numerous studies have shown that CD4
 
  
 
CD8
 
low
 
thymocytes, which were originally assumed to be in transi-
tion to the CD4 lineage, can give rise to mature CD8 SP
thymocytes as well as mature CD4 SP thymocytes (16–20).
In addition, negative selection signals can lead to coordi-
nate down-regulation of CD4 and CD8 surface levels (21–
23). These complexities arise in part from multiple controls
on surface coreceptor expression including protein turn-
over and mRNA stability, as well as transcription (24, 25).
Attempts to assess CD4 and CD8 commitment using pro-
nase stripping and reexpression assays (18) are subject to
many of the same confounding issues, as well as the poten-
tial artifacts introduced by the pronase treatment itself. Per-
haps the most direct approach to assess the developmental
potential of a thymocyte population is to isolate the popu-
lation in question and follow its differentiation after transfer
into the thymus or thymic organ culture (16, 17). Al-
though this approach can be informative, the low cell re-
coveries make it difficult to draw firm conclusions regard-
ing the lineage commitment of the starting population.
Previous studies have shown that stable repression of
gene expression can be accompanied by repositioning of
the silenced gene to heterochromatin (12–14). We rea-
soned that the location of the CD4 and CD8 genes relative
to heterochromatin could provide information both about
the mechanism of stable repression of these genes and in-
sights into the timing and mechanism of T cell lineage
commitment. We find that CD4 and CD8 genes tend to be
positioned near heterochromatin in thymocyte and T cell
populations in which they are not expressed. We also show
that the repositioning of CD4 and CD8 near heterochro-
matin can be observed in DP thymocytes undergoing posi-
tive selection. We discuss our results in terms of current
models for the CD4 versus CD8 lineage choice.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6), MHC
 
    
 
(C57BL/6 
 
 
 
2-microglobulin
I-Ab
 
    
 
I-E null; Taconic; reference 26), F5 TCR transgenic
(provided by D. Kioussis, NIMR, London UK; reference 27),
P14 TCR transgenic RAG-2
 
    
 
(Taconic; reference 28), 5CC7
TCR transgenic C57BL/10.A RAG-2
 
    
 
(Taconic; reference
29), AND TCR transgenic (The Jackson Laboratory; reference
30), OT-1, and OT-2 RAG-2
 
    
 
TCR transgenic (31) mice were
bred and maintained in the University of California, Berkeley
mouse facility. All animal procedures were approved by the Ani-
mal Care and Use Committee of University of California, Berke-
ley. Mice between 4 and 12 wk of age were used for analyses (31).
 
Purification of Thymocyte and T Cell Subsets.
 
DP thymocytes
from F5 and P14 TCR transgenic mice were incubated with
anti-CD4 beads and thymocytes from 5CC7 and AND TCR
transgenic mice were incubated with anti-CD8 beads, and the
positive fractions were purified by AutoMacs magnetic bead sep-
aration according to the manufacturer’s guidelines (Miltenyi Bio-
tec). TCR transgenic CD4
 
  
 
SP thymocytes were purified by
negative selection of DP thymocytes with anti-CD8 beads fol-
lowed by positive selection with anti-CD4 beads. CD8
 
  
 
SP thy-
mocytes were similarly purified with beads incubated in the re-
verse order. Whole B6 thymocytes and thymocytes complement
depleted of heat stable antigen–expressing cells were FACS sorted
to isolate B6 DP and SP thymocytes. LN T cells were purified by
negative selection on mouse CD3
 
  
 
mini T cell enrichment col-
umns (R&D Systems). Populations were determined to be 90–
99% pure based on flow cytometry. For activation of mature T
cells, LN cells were cultured at a concentration of 10
 
6
 
/ml in pres-
ence of 1 
 
 
 
g/ml Con A for 48 h. CD4
 
  
 
T cells from cultures
were isolated by positive selection using anti-CD4 beads.
 
DPK In Vitro Differentiation.
 
DCEK cells, an L cell derivative
transfected with I-E
 
k
 
, were pretreated with mitomycin C and
pulsed with PCC peptide. DPK cells (32) were then added at a
concentration of 10
 
6
 
/ml in Click’s media supplemented with
10% fetal calf serum, penicillin, streptomycin, and 50 
 
 
 
M 2-mer-
captoethanol. At the indicated times, DPK cells were removed by
gentle pipetting and analyzed by flow cytometry for CD4, CD8,
and CD69 expression to monitor in vitro differentiation. For
fluorescence in situ hybridization (FISH) analysis, DPK cells were
removed from cocultures by gentle pipetting and FACS sorted
for CD4 expression to exclude DCEK cells from the analysis.
Where indicated, DPK cells from 18-h stimulation cultures were
sorted into CD4
 
  
 
CD69
 
  
 
and CD4
 
  
 
CD69
 
  
 
fractions by FACS
before analysis by FISH.
 
FISH.
 
The CD4 probe was a 10-kb insert from a 
 
  
 
genomic
clone (provided by A. Rahemtulla, University of Oxford, Oxford,
UK). The CD8
 
  
 
probe was a 30-kb insert from a CD8 genomic
cosmid clone (provided by D. Kioussis). CD4 and CD8
 
  
 
probes
were labeled with digoxigenin and the 
 
  
 
satellite probe was labeled
with FITC using a nick translation kit (Roche Applied Science)
according to the manufacturer’s instructions. 
 
  
 
satellite and CD4
or CD8
 
  
 
genes were detected as described previously (14) with
small modifications. In brief, cells fixed with NaBH4 were blocked
in 1% BMB blocking reagent (Roche Applied Science) containing
50 ug/ml herring sperm DNA for 2 h at 37
 
 
 
C. Probes were dena-
tured in 50% formamide/10% dextran sulfate in 2X SSC at 94
 
 
 
C
for 4 min, and then incubated at 37
 
 
 
C for 10 min. Chromosomal
DNA was denatured in 50% formamide/2X SSC at 94
 
 
 
C for 4
min. Hybridization was performed overnight at 37
 
 
 
C in humid
chambers. Digoxigenin-labeled probes were detected with sheep
anti–digoxigenin-rhodamine (Roche Applied Science) and for
CD4 detection, were amplified with donkey anti–sheep IgG-
rhodamine (Jackson ImmunoResearch Laboratories).
Cells were stained with DAPI and analyzed using multiwave-
length wide-field, three-dimensional microscopy with computer-
driven shutters, filter wheels, focus movement, and data collection.
For fluorescence analysis of fixed cells, data stacks of immunoflu-
orescent images were acquired in the FITC and rhodamine chan-
nels by moving the stage in successive 0.25-
 
 
 
m focal planes
through the sample. Out of focus light was removed with a near-
est neighbor deconvolution algorithm. Data were scored manu-
ally by identifying cells that had one or two clear signals for the 
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signal copy probe. The proximity of each allele to 
 
  
 
satellite
probe was assessed by examination of all focal planes. A number
of samples were rescored after being identified only by letter. In
each case the values for percent of alleles associated with 
 
  
 
satel-
lite probe agreed within 3%.
 
Flow Cytometry.
 
Thymocytes were examined by three-color
flow cytometry using combinations of anti-CD4, anti-CD5, anti-
CD8, anti-CD69, and anti–TCR antibody conjugated to FITC,
phycoerythrin, or phycoerythrin-Cy5 (BD Biosciences and eBio-
science), and anti-CD4 and anti-CD8 conjugated to phycoeryth-
rin Texas red (Caltag). Cells were processed on a Coulter Epics
XL-MCL and analyzed using FlowJo software (Tree Star).
 
Results
 
To examine the location of the CD4 and CD8 genes rel-
ative to heterochromatin, we used the technique of FISH.
In this technique nuclei are stained with a gene-specific
probe together with a probe for 
 
  
 
satellite DNA as a marker
for centromeric heterochromatin, and individual alleles are
scored as being associated with heterochromatin. Analysis of
various thymocyte and T cell populations revealed a strong
correlation between expression of CD4 and CD8 and their
association with heterochromatin (Figs. 1 and 2). Both
genes were strongly associated with heterochromatin in
early CD4
 
  
 
CD8
 
  
 
DN thymocytes (76–78% of alleles), but
only weakly associated (18–35%) in CD4
 
  
 
CD8
 
  
 
DP thy-
mocytes. In addition, the lineage-specific repression of CD4
and CD8 in mature CD4
 
  
 
CD8
 
  
 
and CD4
 
  
 
CD8
 
  
 
SP thy-
mocytes was accompanied by repositioning of the repressed
coreceptor gene to heterochromatin. Importantly, the ex-
tent of heterochromatin association was similar between
mature peripheral T cells and SP thymocytes, implying that
repositioning to heterochromatin is an early event after pos-
itive selection. It is also interesting to note that the extent of
heterochromatin association of the repressed coreceptor
gene in mature T cells and thymocytes (52–67%) was less
pronounced than the association seen in early DN thy-
mocytes. This may reflect a difference in the mechanism of
repression of a gene that has been recently expressed versus
one that has not. Together, these data indicate that the in-
Figure 1. Analysis of the position of CD4 and CD8 alleles relative to heterochromatin using FISH analysis. Thymocyte or T cell populations were iso-
lated and analyzed by FISH using probes for either CD4 (a–d) or CD8  (e–j) genes (red). Samples were costained with probes for   satellite DNA (green)
as a marker for heterochromatin as described in Materials and Methods. DAPI staining (blue) is included to help locate the nucleus. Examples of associated
alleles are shown on the left and examples of nonassociated alleles are shown on the right. Representative deconvolved fluorescent images are shown for the
following samples: (a) CD4  CD8  thymocytes from RAG-1  mice, (b) CD4  CD8  thymocytes from P14 TCR transgenic mice, (c) CD4  CD8  LN T
cells from wild-type mice, (d) CD4  CD8  thymocyte from F5 TCR transgenic mice, (e) CD4  CD8  thymocytes from RAG-1  mice, (f) CD4  CD8 
thymocytes from 5CC7 TCR transgenic mice, (g) CD4  CD8  thymocytes from wild-type mice, (h) CD4  CD8  thymocytes from F5 TCR transgenic
mice, (i and j) activated CD4  CD8  LN T cells. (i and j) Two different focal (z) planes of the same cell taken 1.8  m apart are shown. Compiled data for
percent of alleles associated are shown in Figs. 2 and 3. Note that each image corresponds to a single focal plane, however complete z-series for each cell
was recorded and individual alleles were scored as associated or nonassociated with heterochromatin based on examination of all focal planes. 
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duction and repression of the CD4 and CD8 genes during
different stages of T cell development correlates with their
association with centromeric heterochromatin.
It is interesting that the heterochromatic association of
the CD4 and CD8 genes was maintained in resting mature
T cells. This is in contrast to studies with B cells, in which
heterochromatic association of repressed genes was observed
in B cell lines and activated B cells, but not seen in resting
primary B cells (13). In contrast, the percent of CD8 alleles
associated with heterochromatin did not change signifi-
cantly upon activation of mature CD4 T cells (Fig. 2 A, last
two bars). It is also noteworthy that 20–35% of cells that
lack expression of CD4 or CD8 do not score as showing
heterochromatin-associated alleles in our assay. One possible
explanation is that there are additional sites of heterochro-
matin that are not revealed by the 
 
  
 
satellite probe. It is also
possible that events can lead to transcription silencing of
some alleles independent of heterochromatin association.
Because the relocalization of CD4 and CD8 genes is likely
to reflect their stable repression, information about the timing
of this repositioning, and in which population it occurs, could
give insights into the process of lineage commitment. In par-
ticular, evidence for repositioning of CD4 and CD8 genes to
heterochromatin in DP thymocytes undergoing positive se-
Figure 2. Dynamic repositioning of CD4 and CD8 genes relative to heterochromatin during T cell development. The indicated thymocyte and T cell
populations were isolated and analyzed by FISH using probes for either CD8  (A) or CD4 (B) genes. Samples were costained with probes for   satellite
DNA as a marker for heterochromatin. Individual CD4 or CD8 alleles were scored for association with heterochromatin and the percent of alleles asso-
ciated with heterochromatin is displayed. The number of alleles scored for each sample is indicated beneath each set of bars. Data are compiled from two
to four independent experiments for each sample. Samples are denoted as follows: rag-, thymocytes from RAG-1–deficient mice that were  95%
CD4 CD8 ; DPK, a CD4  CD8  thymocyte cell line (reference 32); B6, isolated CD4  CD8  thymocytes from wild-type C57Bl/6 mice; MHC-, iso-
lated CD4  CD8  thymocytes from  -2 microglobulin and Ab mutant mice; 5CC7-b, isolated CD4  CD8  thymocytes from 5CC7 TCR transgenic
mice on a nonselecting (B10) background; thy CD8, isolated CD4  CD8  thymocytes from F5 TCR transgenic mice; LN CD8, isolated CD4  CD8 
LN cells from wild-type mice; thy CD4, isolated CD4  CD8  thymocytes from 5CC7 TCR transgenic mice on a positive selecting background (B10.A);
LN CD4, isolated CD4  CD8  LN cells from wild-type mice; LN CD4 act, LN CD4 cells that were activated in the presence of Con A for 2 d. Similar
trends are seen when data is scored as percent of cells with one or two alleles associated with heterochromatin (not depicted).
Figure 3. Repositioning of CD8 and CD4 genes to heterochromatin can begin during the DP stage. DP thymocyte populations from the indicated
TCR transgenic mice were isolated and analyzed by FISH for CD8 (A) and CD4 (B). For comparison, the ranges for percent of centromeric alleles for SP
and nonselecting DP thymocytes from Fig. 2 are indicated as bars. For nonselecting DP, this range includes values for the DP cell line DPK, DP thymocytes
from wild-type mice, which contain a low proportion of cells undergoing positive selection, DP thymocytes from MHC mice, and DP thymocytes from
mice expressing a nonselectable TCR transgene. Individual CD4 or CD8 alleles were scored as being associated or not with heterochromatin. The number
of alleles scored for each sample is indicated beneath each set of bars. 
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lection could provide an early indication of their lineage
choice. Although we did not observe a significant increase in
the percent of alleles associated with heterochromatin in DP
thymocytes from wild-type mice compared with DP from
mice that cannot undergo positive selection (MHC-null or
the nonselecting TCR transgenic mice 5CC7-B10), this may
reflect the fact that only a small fraction of thymocytes in
wild-type mice can undergo positive selection.
To examine whether repositioning to heterochromatin
occurs in DP thymocytes undergoing positive selection, we
performed FISH analysis from DP thymocytes from mice
expressing rearranged TCR transgenes that can induce pos-
itive selection (Figs. 1 and 3). Interestingly, DP thymocytes
from all three of the class I–restricted TCR transgenic mice
examined (F5, P15, and OT1) showed significant reposi-
tioning of the CD4 gene, but not the CD8 gene, to het-
erochromatin. The proportion of CD4 alleles associated
with heterochromatin in class I–restricted DP thymocytes
(43–50%) was intermediate between the amount of associa-
tion seen in nonselecting DP thymocytes (21–31%) and the
amount seen in mature CD4
 
  
 
CD8
 
  
 
cells (63–67%). This
partial relocalization might be due to the fact that not all
DP thymocytes in TCR transgenic mice complete positive
selection (33, 34). Alternatively, it could reflect the fact that
CD4
 
  
 
CD8
 
  
 
populations contain cells at different stages of
the selection process, and the process of relocalization to
heterochromatin is ongoing during the DP stage. In either
case, these data indicate that repositioning of the CD4 gene
to heterochromatin occurs early during class I positive se-
lection. Moreover, the observation that the CD4 gene, but
not the CD8 gene, repositioned to heterochromatin sug-
gests that most DP thymocytes being selected via MHC
class I are choosing the CD8 lineage.
In contrast, the pattern of coreceptor gene relocalization
for three class II–restricted TCR transgenic thymocytes
(5CC7-B10A, AND, and OT2) was less clear cut (Fig. 3).
DP thymocytes from 5CC7-B10A mice displayed relocaliza-
tion of CD8 and not CD4. This is in line with results from
class I–restricted TCRs and fits with the idea that these DP
thymocytes are becoming committed to the CD4 lineage.
However, DP thymocytes from AND TCR transgenic mice
did not display significant repositioning of either coreceptor
gene. This might indicate that a relatively low proportion of
DP thymocytes in these mice have begun the process of lin-
eage commitment. DP thymocytes from OT2 TCR trans-
genic mice showed significant repositioning of the CD8
gene to heterochromatin. In addition, there was also a slight
increase in the percent of CD4 alleles associated with hetero-
chromatin on OT2 DP thymocytes relative to nonselected
DP thymocytes. The different patterns of CD4 and CD8
gene relocalization seen with class II–restricted TCR, and
particularly indications of repositioning of the CD4 gene to
heterochromatin in DP thymocytes from OT2 TCR trans-
genic mice, suggests that lineage commitment of class II–
restricted thymocytes may involve a more complex series of
events than those that occur for class I–restricted thymocytes.
These differences may reflect differences in the timing, lev-
els, and avidity of particular transgenic TCRs examined.
The observation that relocalization of the CD4 and CD8
genes to heterochromatin was detectable in DP from TCR
transgenic mice suggests that this repositioning might rep-
resent an early response to lineage commitment signals. In
fact, given the estimated lifespan of 1–3 d for DP thy-
mocytes from TCR transgenic mice (33, 34), it seems
likely that the repositioning begins within 1 d of initiating
positive selection. To gain further information about the
timing of repositioning to heterochromatin, we turned to a
cell line model for positive selection, the CD4
 
  
 
CD8
 
  
 
thy-
mocyte cell line, DPK (32). DPK cells respond to TCR
stimulation by down-regulating CD8 surface expression,
along with other phenotypic changes that mimic the DP to
CD4SP transition. Thus, this cell line provides the oppor-
tunity to examine the repression of the CD8 gene by posi-
tive selection in a synchronized system. We examined loca-
tion of the CD8 gene at 6 and 18 h after TCR stimulation,
well before the down-regulation of surface CD8 is detect-
able. We found that stimulation of DPK cells for 18 h led
to a slight increase in association of the CD8 gene with
heterochromatin from 24 to 28% associated (Fig. 4). This
modest relocalization of CD8 could reflect the fact that not
all DPK cells in the culture respond to TCR engagement.
Indeed, in our hands only 
 
 
 
30% of DPK cells showed
CD8 surface down-regulation 2 d after TCR stimulation
and only 15% of DPK cells up-regulated CD69 18 h after
TCR stimulation (not depicted). Therefore, we sorted the
DPK cells from the 18-h stimulation cultures into CD69
 
 
 
and CD69
 
  
 
fractions, and subjected them to FISH analysis.
CD69
 
  
 
DPK cells displayed 58% of CD8 alleles associated
with heterochromatin, compared with 25% for CD69
 
 
 
cells. Together, these data indicate that CD8 locus under-
goes substantial relocalization to heterochromatin as early as
Figure 4. Rapid relocalization of a CD8 gene after TCR stimulation of
DPK cells. DPK cells were stimulated for 6 or 18 h by coculture with
DCEK cells bearing MHC class II I-EK and cytochrome C peptide, and
analyzed by FISH. The number of alleles scored for each sample is indi-
cated beneath each set of bars. The percent of CD69  cells within each
population is indicated. DPK cells from the 18-h time point were also
sorted into CD69  and CD69  fractions before FISH analysis. After 48 h
of stimulation, a substantial fraction of DPK cells down-regulate surface
CD8 expression; however, at 18 h, surface levels of CD4 and CD8 remain
unchanged (reference 32 and not depicted). No increase in the percent of
CD4 alleles associated with centromeric heterochromatin was observed at
any time point (not depicted). 
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18 h after TCR engagement, and well before the down-
regulation of surface CD8 is detectable.
Association of genes with heterochromatin often corre-
lates with transcriptional repression. If this correlation holds
for the CD4 and CD8 genes, then steady-state mRNA lev-
els might correlate with repositioning of CD4 and CD8
genes to heterochromatin, and might provide equivalent in-
formation regarding lineage commitment. However, gene
repression can occur in the absence of heterochromatic as-
sociation when repression is a transient event (13). More-
over, previous analysis of cell surface levels of CD4 and
CD8 indicated that expression of both coreceptors is re-
pressed by positive selection via MHC class I and II, as well
as by negative selection (19, 21–23). This down-regulation
appears to result in part from destabilization of CD4 and
CD8 mRNA, in addition to transcriptional repression (24).
These observations suggest that CD4 and CD8 mRNA lev-
els in DP thymocytes might not reflect stable repression of
the CD4 and CD8 genes, and would likely not correspond
to the degree of association with heterochromatin.
To examine this issue more directly, we analyzed CD4
and CD8 mRNA levels in DP thymocytes from TCR
transgenic mice using DNA microarrays. Our previous
DNA microarray analysis indicated that CD4 and CD8
steady-state mRNA levels are coordinately repressed dur-
ing positive selection (35). However, because this work
was focused on global changes in gene expression, our ear-
lier analysis did not permit careful quantitative comparisons
between samples or the statistical analysis of the differences
in individual genes observed. Therefore, we reanalyzed our
microarray data to focus on differences in CD4 and CD8
gene expression (Fig. 5). Consistent with other studies, we
found that down-regulation of steady-state CD4 and CD8
mRNA was a general feature of positive selection, regard-
less of TCR specificity. In addition, in some cases we ob-
served a decrease in steady-state mRNA levels in samples
that did not show any detectable increase in heterochroma-
tin localization (e.g., AND DP for CD4 and CD8, 5CC7-
B10A DP for CD4, and P14 and F5 DP for CD8). The
lack of correlation between steady-state mRNA and CD4/
CD8 gene position implies that the early down-regulation
of coreceptor mRNA in response to TCR engagement
probably does not involve relocalization to heterochroma-
tin, and might be distinct mechanistically from stable lin-
eage-specific repression.
 
Discussion
 
One obstacle to a mechanistic understanding of CD4 ver-
sus CD8 lineage commitment is the lack of early markers for
the lineage commitment process. Lineage commitment is as-
sociated with stable repression of CD4 or CD8 genes, an
event that can be accompanied by positioning of loci near
regions of heterochromatin. In this work we have examined
the position of CD4 and CD8 loci relative to heterochroma-
tin at different stages of thymic development to gain insight
into the timing and mechanism of stable gene repression and
lineage commitment. We found that CD4 and CD8 loci
tended to be located near centromeric heterochromatin in
early thymocytes that have not yet expressed CD4 or CD8,
and in mature thymocytes and T cells that have repressed ei-
ther CD4 or CD8. We also provided evidence that reposi-
tioning of CD4 or CD8 genes to heterochromatin can occur
as an early response to positive selection, being detectable in
CD4
 
  
 
CD8
 
  
 
thymocytes that are receiving positive selection
signals. This implies that relocalization of either CD4 or
CD8 genes to heterochromatin represents an early event
during CD4/CD8 lineage commitment.
Figure 5. CD4 and CD8 mRNA
levels from DP thymocytes. Values
for CD4 and CD8 mRNA levels are
from published DNA microarray
analysis (reference 35). Data are re-
plotted here to show values for each
individual measurement. Data are
presented as the log2 ratio of signal
from the indicated CD4  CD8  thy-
mocyte sample relative to CD4 
CD8  thymocytes from MHC-defi-
cient mice. Each dot represents the
value from an individual spot and
the average fold change for all mea-
surements for each sample is shown
as a line. Average fold changes for
CD8   mRNA were as follows:
MHC v B6 0.012(0.15), 5CC7
TCR   1.57(0.26), AND TCR
 1.10(0.44), F5  0.81(0.23), and
P14   0.75(0.16). Average fold
changes for CD4 mRNA were as
follows: MHC v B6  0.22(0.33),
5CC7 TCR  1.46(1.30), AND
TCR  1.94(0.71), F5  1.09(0.51),
and P14  0.42(0.880). Standard er-
rors of means are given in parenthesis.Delaire et al. 1433
Lineage commitment might best be thought of as a series
of gradual steps, rather than a single discrete event. At the
beginning of the process, a precursor cell has an equal prob-
ability of adopting alternative fates. At an intermediate stage
in the process, changes accumulate that increase the likeli-
hood that a precursor will adopt one fate over another. An
example of such an intermediate phase in lineage commit-
ment has been described during vulval development in Cae-
norhabditis elegans (36). In this example, changes in expres-
sion levels of the Notch family member, lin-12, predict the
ultimate fate of a precursor cell, even while the cell remains
plastic. Finally late in the lineage commitment process, addi-
tional steps reinforce the cell fate decision. An example of a
late, reinforcing event is the expression of Pax5 in develop-
ing B cells that represses alternative blood cell fates (37).
The association of the CD4 and CD8 genes with hetero-
chromatin is likely to represent one of several steps that oc-
cur as an uncommitted CD4  CD8  thymocyte differenti-
ates into a peripheral CD4  or CD8  T cell.
With this in mind, it is worth considering how reposi-
tioning of CD4 and CD8 genes to heterochromatin relates
to other events that occur as part of lineage commitment.
With regard to silencing of the CD4 locus in CD8 lineage
cells, two distinct phases have been identified (38). The ini-
tiation of silencing is controlled by a silencer element in the
first intron of the CD4 gene (4) and is mediated by Runx
transcription factors (5–7). This phase occurs in the thy-
mus, and is likely to be closely linked to the repositioning
of the locus near heterochromatin described here. Perhaps
the positioning of the CD4 gene near heterochromatin fa-
cilitates silencing by bringing the locus into proximity with
machinery that represses transcription, such as histone-mod-
ifying enzymes, or by preventing access to factors that would
promote transcription. Runx protein binding to the si-
lencer could lead to the recruitment of the CD4 locus to
heterochromatin, or alternatively, recruitment of the locus
to heterochromatin by other factors could facilitate the
binding or activity of Runx proteins.
In contrast, the maintenance of CD4 silencing, which is
not dependent on the intronic silencer, occurs after mature
CD8 SP T cells leave the thymus (38). It appears that this
later maintenance phase of CD4 silencing is not accompanied
by increased association of the CD4 gene with heterochro-
matin because we find a similar percent of CD4 alleles associ-
ated with heterochromatin in thymic CD8 SP and peripheral
CD8 SP. Thus, a picture emerges in which positive selection
via MHC class I leads to initial CD4 repression via the si-
lencer and the repositioning of CD4 gene near heterochro-
matin as an early step in lineage commitment. Some time
later, after the mature CD8 cell leaves the thymus, the repres-
sion of the CD4 gene is reinforced by a distinct mechanism
that locks the CD4 gene into its silent state without increasing
the percent of alleles associated with heterochromatin.
Other transcription factors have been implicated in the
development of CD4 or CD8 lineage T cells, including
GATA3, Tox, and SAF (9–11, 39). For example, loss of
function of GATA3 prevents CD4 T cell development,
and GATA3 expression is up-regulated early after CD4-
inducing positive selection signals (9, 10). This suggests the
possibility that GATA3 up-regulation may lead, directly or
indirectly, to the repositioning of the CD8 locus close to
heterochromatin in CD4 lineage cells. It will be interesting
to examine the relationship between the activity of factors
such as GATA3 and the nuclear position of the CD4 and
CD8 genes during positive selection.
Our results have implications for the question of how
TCR specificity for MHC class I or II influences the CD4/
CD8 lineage choice. If recognition of MHC class I or II di-
rects the lineage choice at the CD4  CD8  stage (instruc-
tive model), we would expect that DP thymocytes un-
dergoing selection via MHC class I recognition would
exclusively relocalize the CD4 gene, whereas DP thymo-
cytes undergoing selection via class II would relocalize only
the CD8 gene. We find that this prediction holds for three
different class I–restricted TCRs. Thus, for positive selec-
tion of class I–restricted thymocytes, our data fit well with a
simple instructive model for lineage commitment.
In contrast, positive selection of thymocytes bearing class
II–restricted TCRs provides a more complex picture. DP
thymocytes from 5CC7 TCR transgenic mice showed re-
positioning of CD8, and not CD4, as predicted by instruc-
tive models. In contrast, we did not observe significant re-
positioning of either CD4 or CD8 genes in DP thymocytes
from AND TCR transgenic mice, a result that is likely a
reflection of the low proportion of DP thymocytes in these
mice that are engaged in the process of positive selection.
In support of this idea, an independent study found evi-
dence for CD8 repositioning in a selected subset of surface
CD8low DP thymocytes from AND TCR transgenic mice
(40). However, this population made up only 20% of DP
thymocytes, and thus repositioning might be difficult to
detect within the entire DP population.
Most surprisingly, we found that DP thymocytes bearing
the class II–restricted OT-2 TCR showed some evidence for
repositioning of CD4 as well as CD8 genes. There are several
possible interpretations of this result. One possibility is that
the relocalization of CD4 to heterochromatin in DP thy-
mocytes from OT-2 TCR transgenic mice occurs in re-
sponse to negative selection, rather than positive selection
signals. Although these mice are generally thought of as
models for positive selection, there is evidence that some
negative selection can also occur in positively selecting TCR
transgenic mice (41, 42). Thus, negative selection signals
could induce the repositioning of both CD4 and CD8 genes
to heterochromatin, a possibility that could contribute to the
coordinate down-regulation of surface CD4 and CD8 that is
observed in thymocytes undergoing negative selection (21–
23). It is also possible that relocalization of the CD4 gene to
heterochromatin occurs early in the response to class II posi-
tive selection, but can be reversed as cells continue through
the positive selection process. Both of these explanations pre-
dict that CD4 and CD8 genes might reposition to hetero-
chromatin in the same cells. We cannot at present determine
whether CD4 and CD8 repositioning occurs in the same or
different populations of thymocytes due to the technical dif-
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Perhaps the most interesting possibility is that DP thy-
mocytes expressing the OT-2 TCR consist of mixtures of
thymocytes choosing the CD4 or CD8 lineages. Indeed,
numerous studies suggest that some class II–restricted thy-
mocytes may down-regulate CD4 instead of CD8, but that
most of these mismatched thymocytes fail to complete pos-
itive selection because they lose the ability to recognize
MHC class II as they mature (stochastic/selection model;
references 43–46). In fact, mixed models incorporating ele-
ments of both instructive and stochastic models have been
proposed in which MHC recognition imposes an instruc-
tive bias on lineage choice, and the continued requirement
for expression of the appropriate coreceptor later during se-
lection serves to reinforce this bias (47).
Our results are compatible with the widely held quantita-
tive model for CD4/CD8 lineage commitment. This model
was originally proposed based on the differential ability of
CD4 and CD8 cytoplasmic domains to recruit the tyrosine
kinase, Lck, and promote CD4 or CD8 development (41,
48). Subsequently, a number of approaches that have altered
the strength or duration of signaling during positive selec-
tion have provided additional support for this model (for re-
view see references 49 and 50). We propose that the weak
or transient signals generated during positive selection via
MHC class I recognition are sufficient to induce relocaliza-
tion of the CD4 gene, but not the CD8 gene, to hetero-
chromatin. In contrast, stronger, or more prolonged signal-
ing generated during positive selection via MHC class II
would be required to induce relocalization of the CD8
gene. For certain TCRs, positive selection could lead to
mistakes in the initial lineage choice. In these cases, the re-
quirement for prolonged MHC recognition would serve as
a check to ensure that thymocytes that down-regulate the
wrong coreceptor do not complete positive selection.
In summary, our data indicate that changes in the nu-
clear position of CD4 and CD8 genes can be used to mon-
itor lineage commitment during thymic development. When
used in combination with other assays, such as those that
monitor the developmental potential of cells and the activ-
ity of transcription factors, this approach may provide a
new tool to help to unravel the complex, multi-step pro-
cess of lineage commitment.
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